Bayer announced the FDA approved finerenone, a nonsteroidal selective mineralocorticoid receptor antagonist, for the ...

The US regulator has cleared use of Kerendia (finerenone) for the treatment of heart failure patients who have a left ...

Experts say the sentiment weakened amid heightened global trade tensions following US President Donald Trump’s renewed tariff ...

InCred Asset Management is cautious about US-facing generic pharma companies due to potential tariff risks and single-digit earnings growth. They favor domestic pharma companies with strong brands and ...

Analysts on Wall Street project that Novartis (NVS) will announce quarterly earnings of $2.38 per share in its forthcoming report, representing an increase of 20.8% year over year. Revenues are ...